January 2019 FDA Recall Drug by Dr. Reddy's Laboratories, Inc.
D-0389-2019 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on January 15, 2019 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0389-2019

Reason for Recall
Presence of Foreign Substance: Product complaint of black speckles observed on tablets.
Initiated
01-15-2019
Reported
01-30-2019
Quantity
118 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dr. Reddy's Laboratories, Inc.
Nationwide within the United States
Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count bottles, Rx only, Manufactured by: Teva Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10

Batch or Lot Expiration Information

Lot# : 43E021 and 43E023, Exp. 01/2020